Study patients were randomised to receive one of two treatments : A - RBV for @ weeks followed by combined therapy with peg-IFN alpha-@a + RBV for @ weeks ( n = @ ) , or B - combined therapy with peg-IFN alpha-@a + RBV for @ weeks ( n = @ ) .